Literature DB >> 3363527

Should thromboprophylactic dosage of low molecular weight heparin be adapted to patient's weight?

J F Vitoux, M Aiach, M Roncato, J N Fiessinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3363527

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  5 in total

1.  Major orthopaedic surgery on the leg and thromboembolism.

Authors:  J Parker-Williams; R Vickers
Journal:  BMJ       Date:  1991-09-07

Review 2.  Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations.

Authors:  Jeremy W Vandiver; Leticia I Ritz; Jeffrey T Lalama
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

3.  Enoxaparin dosing in the elderly using adjusted body weight.

Authors:  Frederick Leri; Stephen J Voyce; Salvatore Scialla; William Glavich; Edward Dzielak; Raymond A Smego; John Guzek
Journal:  J Thromb Thrombolysis       Date:  2009-03-13       Impact factor: 2.300

4.  Weight-based dosing of enoxaparin for VTE prophylaxis in morbidly obese, medically-Ill patients.

Authors:  Matthew T Rondina; Michelle Wheeler; George M Rodgers; Leslie Draper; Robert C Pendleton
Journal:  Thromb Res       Date:  2009-03-09       Impact factor: 3.944

Review 5.  Nadroparin calcium. A review of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disorders.

Authors:  L B Barradell; M M Buckley
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.